International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.
about
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate TherapiesSpinal osteosarcomaChildren's Oncology Group's 2013 blueprint for research: bone tumorsThe DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formationReview of Osteosarcoma and Current ManagementGermline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.Incidence and survival of malignant bone sarcomas in England 1979-2007.Incidence patterns of primary bone cancer in taiwan (2003-2010): a population-based study.LIM mineralization protein-1 inhibits the malignant phenotypes of human osteosarcoma cells.β-Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour.Suppression of osteosarcoma cell invasion by chemotherapy is mediated by urokinase plasminogen activator activity via up-regulation of EGR1.A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma.Animal models in osteosarcoma.Review of mifamurtide in the treatment of patients with osteosarcoma.Targeting Notch1 signaling pathway positively affects the sensitivity of osteosarcoma to cisplatin by regulating the expression and/or activity of Caspase familyOsteosarcoma in children 5 years of age or younger at initial diagnosisWnt/β-catenin expression does not correlate with serum alkaline phosphatase concentration in canine osteosarcoma patientsStrategies for the targeted delivery of therapeutics for osteosarcoma.UK Guidelines for the Management of Bone Sarcomas.Using epidemiology and genomics to understand osteosarcoma etiology.NFKB1 -94ins/del ATTG polymorphism increases osteosarcoma risk in a Chinese Han populationTime-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcomaPreclinical mouse models of osteosarcomaDeveloping and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008Effect of variation of FGF2 genotypes on the risk of osteosarcoma susceptibly: a case control study.Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review.At-risk populations for osteosarcoma: the syndromes and beyond.Expression of epidermal growth factor-like domain 7 correlates with clinicopathological features of osteosarcomaSunitinib malate (SU-11248) reduces tumour burden and lung metastasis in an intratibial human xenograft osteosarcoma mouse model.A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with OsteosarcomaLung cells support osteosarcoma cell migration and survival.Germline TP53 variants and susceptibility to osteosarcoma.The effect of bone morphogenetic protein-2 on osteosarcoma metastasis.Height at diagnosis and birth-weight as risk factors for osteosarcomaCase-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study.Genetically engineered mouse models and human osteosarcoma.Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma.The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years.Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison.
P2860
Q26782646-1B03E6DC-A088-4F61-BDC1-C8C23779681DQ26996533-0A2B1883-EDAD-4587-B23A-A6F02B90834DQ27027664-A29DA5AD-1AB3-4F5A-AD3B-69CE38FFC770Q27311269-690BC71D-D55E-44EF-A7E5-76C79E3FF290Q28077590-A64AA094-71D0-49E4-A702-59BA7304234FQ30235105-B360D68C-8E05-4E0D-AC1E-6E6E46BCFBD9Q33274226-73AC18EB-733D-40B2-85D0-C70360885C99Q33275216-5B8F93E9-E1D6-4A77-B0D6-5245F23B7D5AQ33580856-ACCEB7F6-02AB-42BD-8EC1-E2B4520CB856Q33645914-46A1905F-1C05-4D84-B62E-F12273D5E15DQ33809324-5B891912-2CFF-4FF5-9ACA-86A951F1CE16Q33914489-1E5B1E62-7B07-47BA-941B-0762CEF346EAQ33917772-EBB81F51-32C3-4F8B-B39A-67EFD4784A9AQ33947618-4C61489B-DF3D-4556-AE62-2EE74080A208Q33948137-B04D38AB-8168-4631-9798-1AB0CF6D8BA2Q34049526-1E674AB1-FE88-4397-B2B3-403A21AB8E40Q34056006-837E00DE-4B28-4862-9113-F9E465BF81F8Q34179495-CA6B9E88-2C49-4DE6-825C-50EA456888A1Q34496992-E5DF568A-1721-4750-B46B-84C3EDC973C3Q34627943-2DB5772B-7239-4925-9BF9-9DDACF0C58FAQ35173942-F60FCD9B-01A3-46FE-87CB-5AE5FDA49D99Q35190158-2D2F0B03-F540-45EF-AD52-AB0256719016Q35575644-9D25563C-30A4-447F-BE9A-042F457658F6Q35653897-4366C062-B501-4468-ACF5-ACBFA58AB02EQ35766581-A3D34AFF-B735-46C6-B8F7-F16A07A10804Q35791674-F4393DAB-15AC-4A57-842B-4A8ABA04C692Q35848126-FFBD927C-E3FF-4A63-B532-B983C07DD932Q35897747-255F7BB8-68C0-470C-ADC7-AD47A7F69960Q35993067-ED06FF56-55BA-4348-AFF9-5763362658FDQ35993110-244CD570-EB65-4EC0-B369-08719A9E38D4Q36029709-872898AA-AD2B-40E6-8C56-5741D58BC08DQ36260257-ED584F32-019E-4986-B720-762AD6E46713Q36294747-92D994F4-5906-42C5-A28A-9ABADDB90236Q36298450-1B359A01-6C98-4E87-87AF-8B40136A8D96Q36387760-26EB531C-58EB-46D9-81E2-3C28DBC504EDQ36429557-70ACA37C-6A68-473F-BB13-8518F5E073C2Q36468644-B044930D-C72B-4514-90EA-BC71E90E6842Q36502721-A3B449AA-E9E4-4A76-8923-A602BB751346Q36537388-E2B12F7B-5AA1-43C9-AD4E-EA30BEE98602Q36803705-8E48FF37-FE4C-4B2D-8590-8AD0B640C800
P2860
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
International osteosarcoma inc ...... ddle ages and elderly persons.
@ast
International osteosarcoma inc ...... ddle ages and elderly persons.
@en
International osteosarcoma inc ...... ddle ages and elderly persons.
@nl
type
label
International osteosarcoma inc ...... ddle ages and elderly persons.
@ast
International osteosarcoma inc ...... ddle ages and elderly persons.
@en
International osteosarcoma inc ...... ddle ages and elderly persons.
@nl
prefLabel
International osteosarcoma inc ...... ddle ages and elderly persons.
@ast
International osteosarcoma inc ...... ddle ages and elderly persons.
@en
International osteosarcoma inc ...... ddle ages and elderly persons.
@nl
P2860
P356
P1476
International osteosarcoma inc ...... ddle ages and elderly persons.
@en
P2093
Lisa Mirabello
Rebecca J Troisi
P2860
P304
P356
10.1002/IJC.24320
P577
2009-07-01T00:00:00Z